Market Overview:
The global lidocaine hydrochloride market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The growth in the lidocaine hydrochloride market can be attributed to factors such as rising prevalence of chronic diseases, increasing demand for local numbing agents and growing awareness about the benefits of lidocaine hydrochloride. However, stringent regulatory norms and high cost associated with R&D are some of the major factors restraining the growth of this market. Based on type, the global lidocaine hydrochloride market is segmented into creams, injectables and others. Injectables segment is expected to register highest CAGR during forecast period owing to its advantages such as fast onset action and long duration of effect. Based on application, local numbing agent segment dominates global lidocaine hydrochloride market followed by heart arrhythmia and epilepsy segments respectively.
Product Definition:
Lidocaine Hydrochloride is a local anesthetic drug used to relieve pain. It can be applied topically, injected, or used as an oral spray. Lidocaine Hydrochloride is important because it helps to numb pain and make surgery or other medical procedures more comfortable.
Creams:
Creams are topical medications used for the treatment of skin conditions like acne, psoriasis and eczema. The most commonly used creams are benzoyl peroxide, azelaic acid, and sulfur agents. Increasing prevalence of these diseases is expected to be a key factor driving the market growth over the forecast period.
Injectables:
Injectables are drugs that are administered through the parenteral route. They consist of a drug and an injectable delivery device or ampoules. Injectables can be administered by various routes, including intravenous, subcutaneous, intramuscular, intraperitoneal and intravenous infusion techniques.
Application Insights:
By application, the global market is segmented into local numbing agent, heart arrhythmia, epilepsy, other. In 2017, local numbing agent held the largest share of over 70.0% in terms of revenue and is expected to witness significant growth during the forecast period owing to its wide applications in various medical conditions such as neurogenic pain (neurological), dental pain (dental), and others. Epilepsy also holds a significant share due to its high incidence rate globally coupled with improved treatment options compared to previous years. Other applications include injectable lidocaine hydrochloride for labor analgesia and topical cream formulations for peripheral nerve blocks among others.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a growth rate of 5.6% over the forecast period, owing to increasing cases of local anesthesia and cardiac arrhythmia treatment in the U.S., coupled with rising awareness about lidocaine products among patients and physicians.
Asia Pacific is anticipated to be one of fastest-growing regions during the same period due to rapid economic development along with improving healthcare infrastructure & availability of skilled professionals especially in countries such as India & China which has resulted into high demand for local anesthetics.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.5% from 2016 to 2021. This is primarily owing to the increasing preference for minimally invasive procedures over traditional open surgery procedures, due to their shorter recovery time and lesser surgical trauma. Lidocaine hydrochloride is extensively used as a local anesthetic in these procedures, thereby driving its demand.
- Rising prevalence of chronic pain: According to the World Health Organization (WHO), chronic pain affects around one-third of the global population and costs economies billions of dollars in lost productivity every year. This high prevalence coupled with the lack of effective long-term treatments has led many patients to seek relief through alternative therapies such as lidocaine hydrochloride injections or topical applications.
- Growing geriatric population: The number of people aged 60 years or above is projected to exceed 2 billion by 2050, accounting for nearly one-fourth of the world’s population. This growing geriatric population is more susceptible than younger individuals are too various age-related health conditions such as arthritis, Alzheimer’s disease, and cancer that can cause chronic pain syndromes .This will leadto an increase in demand for lidocaine hydrochloride products specifically designedfor elderly patients suffering from chronic pain conditions .
Scope Of The Report
Report Attributes
Report Details
Report Title
Lidocaine Hydrochloride Market Research Report
By Type
Creams, Injectables, Others
By Application
Local Numbing Agent, Heart Arrhythmia, Epilepsy, Other
By Companies
Pfizer Inc, Sigma-Aldrich Co. LLC, Mahendra Chemicals, Alanza Inc, Ciron Drugs & Pharmaceuticals Pvt. Ltd, P&R Ventures, Medexim India, Zuche Pharmaceuticals Pvt. Ltd, Amphastar Pharmaceuticals, Inc, Nortec Qumica, Pfizer Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Lidocaine Hydrochloride Market Report Segments:
The global Lidocaine Hydrochloride market is segmented on the basis of:
Types
Creams, Injectables, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Local Numbing Agent, Heart Arrhythmia, Epilepsy, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer Inc
- Sigma-Aldrich Co. LLC
- Mahendra Chemicals
- Alanza Inc
- Ciron Drugs & Pharmaceuticals Pvt. Ltd
- P&R Ventures
- Medexim India
- Zuche Pharmaceuticals Pvt. Ltd
- Amphastar Pharmaceuticals, Inc
- Nortec Qumica
- Pfizer Inc
Highlights of The Lidocaine Hydrochloride Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Creams
- Injectables
- Others
- By Application:
- Local Numbing Agent
- Heart Arrhythmia
- Epilepsy
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lidocaine Hydrochloride Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lidocaine hydrochloride is a local anesthetic that numbs the skin and reduces pain. It is used to treat minor cuts, scrapes, and burns.
Some of the key players operating in the lidocaine hydrochloride market are Pfizer Inc, Sigma-Aldrich Co. LLC, Mahendra Chemicals, Alanza Inc, Ciron Drugs & Pharmaceuticals Pvt. Ltd, P&R Ventures, Medexim India, Zuche Pharmaceuticals Pvt. Ltd, Amphastar Pharmaceuticals, Inc, Nortec Qumica, Pfizer Inc.
The lidocaine hydrochloride market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lidocaine Hydrochloride Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Lidocaine Hydrochloride Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Lidocaine Hydrochloride Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Lidocaine Hydrochloride Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Lidocaine Hydrochloride Market Size & Forecast, 2020-2028
4.5.1 Lidocaine Hydrochloride Market Size and Y-o-Y Growth
4.5.2 Lidocaine Hydrochloride Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Creams
5.2.2 Injectables
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Local Numbing Agent
6.2.2 Heart Arrhythmia
6.2.3 Epilepsy
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lidocaine Hydrochloride Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lidocaine Hydrochloride Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Creams
9.6.2 Injectables
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Local Numbing Agent
9.10.2 Heart Arrhythmia
9.10.3 Epilepsy
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Creams
10.6.2 Injectables
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Local Numbing Agent
10.10.2 Heart Arrhythmia
10.10.3 Epilepsy
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Creams
11.6.2 Injectables
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Local Numbing Agent
11.10.2 Heart Arrhythmia
11.10.3 Epilepsy
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Creams
12.6.2 Injectables
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Local Numbing Agent
12.10.2 Heart Arrhythmia
12.10.3 Epilepsy
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Creams
13.6.2 Injectables
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Local Numbing Agent
13.10.2 Heart Arrhythmia
13.10.3 Epilepsy
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lidocaine Hydrochloride Market: Competitive Dashboard
14.2 Global Lidocaine Hydrochloride Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer Inc
14.3.2 Sigma-Aldrich Co. LLC
14.3.3 Mahendra Chemicals
14.3.4 Alanza Inc
14.3.5 Ciron Drugs & Pharmaceuticals Pvt. Ltd
14.3.6 P&R Ventures
14.3.7 Medexim India
14.3.8 Zuche Pharmaceuticals Pvt. Ltd
14.3.9 Amphastar Pharmaceuticals, Inc
14.3.10 Nortec Qumica
14.3.11 Pfizer Inc
